Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from Northwest Bancshares

Stocks To Watch: Northwest Bancshares Sees RS Rating Rise To 81

A Relative Strength Rating upgrade for Northwest Bancshares shows improving technical performance.

Investors Business Daily

Northwest Bancshares Earns Relative Strength Rating Upgrade; Hits Key Threshold

Northwest Bancshares Earns Relative Strength Rating Upgrade; Hits Key Threshold

Northwest Bancshares sees its Relative Strength Rating reach the 80-plus level.

Investors Business Daily

Benzinga's Top Ratings Upgrades, Downgrades For May 6, 2022

Benzinga's Top Ratings Upgrades, Downgrades For May 6, 2022

Upgrades For Coupang Inc (NYSE:CPNG), JP Morgan upgraded the previous rating of Neutral to Overweight. The stock has a 52-week-high of $46.00 and a 52-week-low of $11.91. At the end of the last trading period, Coupang closed at $11.99.

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Tuesday Is Your Last Chance To Buy Northwest Bancshares Before The Dividend Payout

Tuesday marks the last chance for investors to receive the next dividend payout from Northwest Bancshares (NASDAQ:NWBI).

Northwest Bancshares: Q1 Earnings Insights

Northwest Bancshares (NASDAQ:NWBI) reported its Q1 earnings results on Monday, April 25, 2022 at 09:00 AM. Here's what investors need to know about the announcement.

Northwest Bancshares's Ex-Dividend Date Is Tuesday, Here's What You Need To Know

Tuesday marks the last chance for investors to receive the next dividend payout from Northwest Bancshares (NASDAQ:NWBI).

Recap: Northwest Bancshares Q4 Earnings

Northwest Bancshares (NASDAQ:NWBI) reported its Q4 earnings results on Monday, January 24, 2022 at 09:00 AM. Here's what investors need to know about the announcement.

inkl

Read news from The Economist, FT, and more,
with one subscription

Organisations

Cantor Fitzgerald

Canaccord Genuity

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.

Download on the AppStore

Get it on Google Play